Extendicare Announces April 2018 Dividend of C$0.04 per Share
Apr 16, 2018 12:01 pm UTC| Business
MARKHAM, Ontario, April 16, 2018 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month...
Apr 16, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., April 16, 2018 -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for...
Introducing TraNexus - Blockchain ICO Announced, Ushering in New Era in Smarter Travel
Apr 16, 2018 12:01 pm UTC| Business
DUBLIN, Ireland and BRUSSELS, Belgium, April 16, 2018 -- Speaking today, Geoffrey Lipman, long time sustainable travel advocate, announced a new research and delivery program to advance application of the blockchain for...
Apr 16, 2018 12:00 pm UTC| Business
NEW HAVEN, Conn., April 16, 2018 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today...
Apr 16, 2018 12:00 pm UTC| Business
MADISON, Wis., April 16, 2018 -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer,...
Apr 16, 2018 12:00 pm UTC| Business
OMAHA, Neb., April 16, 2018 -- West Corporation (“West” or the “Company”), a global leader in technology-enabled services, announced today it has completed the acquisition of the public relations and digital media...
Foamix Announces $16 Million Investment by OrbiMed
Apr 16, 2018 12:00 pm UTC| Business
REHOVOT, Israel and BRIDGEWATER, N.J., April 16, 2018 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary...